Beat it – Heart disease diagnostic method isn’t patent-eligible
$225.00
Description
Abstract: Inventors in the pursuit of “personalized medicine” patents were likely discouraged by the Federal Circuit Court of Appeals’ ruling in The Cleveland Clinic Foundation v. True Health Diagnostics LLC, which involved a diagnostic method. This article reviews the court’s ruling highlighting the difficulty of obtaining patents for such methods. The Cleveland Clinic Foundation v. True Health Diagnostics LLC, No. 16-1766, June 16, 2017, Fed. Cir.
Additional information
| Year | |
|---|---|
| Niche | |
| Newsletter | |
| Issue | |
| Word Count |